Critical Hodgkin’s Lymphoma cancer study published in the New England Journal of Medicine

John Theurer Cancer Center oncologist, Tatyana Feldman, M.D. is co-author. participated in a pivotal clinical trial for Hodgkin’s Lymphoma. Tatyana Feldman, M.D., director of John Theurer Cancer Center’s T-cell Program at Hackensack University Medical Center, is a co-author of the study, presented at the 59th Annual Meeting of the American Society of Hematology at plenary session and published in the New England Journal of Medicine.

Read full article on